Volume 6, Issue 8, Page 4 (September 2010)
9 of 27
PREVIEW
FULL TEXT
FULL-TEXT PDF (67 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The Food and Drug Administration has approved the first oral solution formulation of glycopyrrolate for the treatment of chronic, severe drooling in children aged 3-16 years with neurologic disorders.
PII: S1553-3212(10)70175-8
doi:10.1016/S1553-3212(10)70175-8
© 2010 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.